REQUEST A DEMO
Total
USD $0.00
Search more companies

Insuasty Oncologia e Investigacion S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Insuasty Oncologia e Investigacion S.A.S. Profile Updated: May 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Insuasty Oncologia e Investigacion S.A.S. is a company in Colombia, with a head office in Bucaramanga. It operates in the Ambulatory Health Care Services industry. The enterprise was incorporated on November 04, 2011. Insuasty Oncologia e Investigacion S.A.S. currently employs 24 (2024) people. The company’s latest financial report indicates a net sales revenue increase of 10.14% in 2023. There was a total growth of 40.99% in Insuasty Oncologia e Investigacion S.A.S.’s total assets over the same period. In 2023, Insuasty Oncologia e Investigacion S.A.S.’s net profit margin decreased by 7.23%.

Headquarters
Calle 54 # 33 - 45 P 11 - 1106 Central de Mezclas - 1105 Sala de Infusion1 P 8 - 805 Servicio Farmaceutico P 10 - 1002 Administracion - 1102 - 1103 - 606 Consultorios - 1004 Sala de Infusion2
Bucaramanga; Santander;

Contact Details: Purchase the Insuasty Oncologia e Investigacion S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Insuasty Oncologia e Investigacion S.A.S. report to view the information.
Outstanding Shares:
Purchase the Insuasty Oncologia e Investigacion S.A.S. report to view the information.
Incorporation Date:
November 04, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Insuasty Oncologia e Investigacion S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
10.14%
Total operating revenue
10.14%
Net Profit (Loss) for the Period
-66.28%
Total assets
40.99%
Total equity
13.57%
Net Profit Margin
-7.23%
Return on Equity (ROE)
-25.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?